EA200301108A1 - Фармацевтическая композиция на основе макролидов для местного применения в офтальмологии - Google Patents
Фармацевтическая композиция на основе макролидов для местного применения в офтальмологииInfo
- Publication number
- EA200301108A1 EA200301108A1 EA200301108A EA200301108A EA200301108A1 EA 200301108 A1 EA200301108 A1 EA 200301108A1 EA 200301108 A EA200301108 A EA 200301108A EA 200301108 A EA200301108 A EA 200301108A EA 200301108 A1 EA200301108 A1 EA 200301108A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- composition
- pharmaceutical composition
- carbon atoms
- carrier
- subject
- Prior art date
Links
- 239000003120 macrolide antibiotic agent Substances 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229940041033 macrolides Drugs 0.000 title 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 3
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 abstract 2
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 abstract 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 abstract 1
- 208000001860 Eye Infections Diseases 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 125000003158 alcohol group Chemical group 0.000 abstract 1
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 abstract 1
- 229960004099 azithromycin Drugs 0.000 abstract 1
- 150000001735 carboxylic acids Chemical class 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 239000003889 eye drop Substances 0.000 abstract 1
- 229940012356 eye drops Drugs 0.000 abstract 1
- 208000011323 eye infectious disease Diseases 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 abstract 1
- 229940057917 medium chain triglycerides Drugs 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 229930195734 saturated hydrocarbon Natural products 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Изобретение относится к фармацевтической композиции для профилактики и/или лечения глазных инфекций, которая подлежит местному введению. Оно направлено, в частности, на создание такой композиции, которая будет иметь форму глазных капель, подлежащих покапельной раздаче, в которых какой-либо антибиотик из класса макролидов, например азитромицин, растворен в маслянистом носителе. Этот носитель выбирается, в частности, из веществ, образованных, по существу, триглицеридами со средней цепью, в которых спиртовые группы глицерина полностью этерифицированы карбоновыми кислотами насыщенных углеводородов, молекула которых имеет от 5 до 12 атомов углерода. Для этого предпочтительно использовать жирные кислоты с линейной цепью, содержащие от 8 до 10 атомов углерода, например каприловую и/или каприновую кислоту. В соответствии с предпочтительным вариантом осуществления изобретения указанную композицию приготавливают путем растворения активного средства в маслянистом носителе при температуре не выше 70°C.Международная заявка была опубликована вместе с отчетом о международном поиске.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0105114A FR2823441B1 (fr) | 2001-04-12 | 2001-04-12 | Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie et son procede de preparation |
| PCT/FR2002/001263 WO2002083178A1 (fr) | 2001-04-12 | 2002-04-11 | Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA200301108A1 true EA200301108A1 (ru) | 2004-04-29 |
| EA008088B1 EA008088B1 (ru) | 2007-02-27 |
Family
ID=8862340
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200301108A EA008088B1 (ru) | 2001-04-12 | 2002-04-11 | Фармацевтическая композиция в форме глазных капель на основе азитромицина, способ ее приготовления и применение азитромицина для получения глазных капель |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US7064109B2 (ru) |
| EP (1) | EP1377316B1 (ru) |
| JP (2) | JP4558275B2 (ru) |
| KR (1) | KR100835002B1 (ru) |
| CN (1) | CN1496270B (ru) |
| AR (1) | AR034033A1 (ru) |
| AT (1) | ATE397460T1 (ru) |
| BR (1) | BRPI0208367B8 (ru) |
| CA (1) | CA2443728C (ru) |
| CY (1) | CY1108302T1 (ru) |
| CZ (1) | CZ300213B6 (ru) |
| DE (1) | DE60226962D1 (ru) |
| DK (1) | DK1377316T3 (ru) |
| EA (1) | EA008088B1 (ru) |
| EG (1) | EG23169A (ru) |
| ES (1) | ES2307754T3 (ru) |
| FR (1) | FR2823441B1 (ru) |
| HR (1) | HRP20030907B1 (ru) |
| HU (1) | HU230459B1 (ru) |
| MA (1) | MA27005A1 (ru) |
| MX (1) | MXPA03009349A (ru) |
| OA (1) | OA12462A (ru) |
| PA (1) | PA8543401A1 (ru) |
| PE (1) | PE20021082A1 (ru) |
| PL (1) | PL204403B1 (ru) |
| PT (1) | PT1377316E (ru) |
| SI (1) | SI1377316T1 (ru) |
| TN (1) | TNSN03091A1 (ru) |
| WO (1) | WO2002083178A1 (ru) |
| ZA (1) | ZA200307718B (ru) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2314354T3 (es) * | 2004-11-09 | 2009-03-16 | Novagali Pharma S.A. | Emulsion de tipo aceite en agua con baja concentracion de agente cationico y potencial zeta positivo. |
| FR2884716B1 (fr) * | 2005-04-22 | 2009-08-21 | Thea Sa Lab | Utilisation de l'azithromycine pour la fabrication d'un medicament destine au traitement des infections oculaires |
| JPWO2007074904A1 (ja) * | 2005-12-28 | 2009-06-04 | わかもと製薬株式会社 | 水性医薬組成物 |
| BRPI0808410A2 (pt) * | 2007-02-28 | 2015-06-23 | Aciex Therapeutics Inc | Métodos e composições para normalizar secreções da glândula meibomiana |
| US20100158821A1 (en) * | 2008-12-22 | 2010-06-24 | Eastman Chemical Company | Antimicrobial agents, compositions and products containing the same, and methods of using the compositions and products |
| CN101780105B (zh) * | 2009-01-20 | 2011-09-28 | 沈阳兴齐制药有限公司 | 小牛血去蛋白提取物的滴眼液 |
| EP2228058A1 (en) | 2009-03-04 | 2010-09-15 | Novagali Pharma S.A. | Anionic oil-in-water emulsion containing prostaglandins and uses thereof |
| US8106111B2 (en) * | 2009-05-15 | 2012-01-31 | Eastman Chemical Company | Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions |
| EP2394636B1 (en) * | 2010-05-28 | 2014-03-19 | Novagali Pharma S.A. | Method for treating retinal conditions using an intraocular tamponade |
| EP2389939A1 (en) | 2010-05-28 | 2011-11-30 | Novagali Pharma S.A. | Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions |
| US9044508B2 (en) * | 2013-03-15 | 2015-06-02 | Insite Vision Corporation | Concentrated aqueous azalide formulations |
| AU2017290256A1 (en) * | 2016-06-29 | 2019-01-17 | Otonomy, Inc. | Triglyceride otic formulations and uses thereof |
| PT3266446T (pt) * | 2016-07-07 | 2019-01-30 | Salvat Lab Sa | Composição oftálmica compreendendo óleo de rícino e triglicérido de cadeia média |
| CN115475248A (zh) * | 2021-06-16 | 2022-12-16 | 云南拜奥泰克生物技术有限责任公司 | 一种新型药用甘油三酯溶剂及其应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1152644A (en) * | 1966-07-01 | 1969-05-21 | Abbott Lab | Stable Solutions of Erythromycin Free Base |
| JPS6468328A (en) * | 1987-09-09 | 1989-03-14 | Suntory Ltd | Anticorneoulcerative |
| JP2563336B2 (ja) * | 1987-06-01 | 1996-12-11 | エーザイ株式会社 | 角膜透過促進点眼剤 |
| FR2746035B1 (fr) * | 1996-03-15 | 1998-06-12 | Microparticules de gel composite susceptibles d'etre utilisees comme vecteur(s) de principe(s) actif(s), l'un de leurs procedes de preparation et leurs applications | |
| EP0925789B2 (en) * | 1997-12-02 | 2009-06-17 | Pfizer Products Inc. | Use of azithromycin in the topical treatment of ocular infections |
| JP2000159659A (ja) * | 1998-11-30 | 2000-06-13 | Kazuo Tsubota | 眼科用人工涙液 |
| US6239113B1 (en) * | 1999-03-31 | 2001-05-29 | Insite Vision, Incorporated | Topical treatment or prevention of ocular infections |
-
2001
- 2001-04-12 FR FR0105114A patent/FR2823441B1/fr not_active Expired - Lifetime
-
2002
- 2002-04-09 PA PA20028543401A patent/PA8543401A1/es unknown
- 2002-04-10 EG EG20020380A patent/EG23169A/xx active
- 2002-04-10 AR ARP020101319A patent/AR034033A1/es not_active Application Discontinuation
- 2002-04-11 HR HR20030907A patent/HRP20030907B1/xx not_active IP Right Cessation
- 2002-04-11 DE DE60226962T patent/DE60226962D1/de not_active Expired - Lifetime
- 2002-04-11 HU HU0303864A patent/HU230459B1/hu unknown
- 2002-04-11 PE PE2002000306A patent/PE20021082A1/es not_active Application Discontinuation
- 2002-04-11 MX MXPA03009349A patent/MXPA03009349A/es active IP Right Grant
- 2002-04-11 CA CA2443728A patent/CA2443728C/fr not_active Expired - Lifetime
- 2002-04-11 SI SI200230723T patent/SI1377316T1/sl unknown
- 2002-04-11 WO PCT/FR2002/001263 patent/WO2002083178A1/fr not_active Ceased
- 2002-04-11 BR BRPI0208367A patent/BRPI0208367B8/pt not_active IP Right Cessation
- 2002-04-11 AT AT02732804T patent/ATE397460T1/de active
- 2002-04-11 CZ CZ20032771A patent/CZ300213B6/cs not_active IP Right Cessation
- 2002-04-11 DK DK02732804T patent/DK1377316T3/da active
- 2002-04-11 PT PT02732804T patent/PT1377316E/pt unknown
- 2002-04-11 EP EP02732804A patent/EP1377316B1/fr not_active Expired - Lifetime
- 2002-04-11 KR KR1020037012372A patent/KR100835002B1/ko not_active Expired - Lifetime
- 2002-04-11 JP JP2002580979A patent/JP4558275B2/ja not_active Expired - Lifetime
- 2002-04-11 ES ES02732804T patent/ES2307754T3/es not_active Expired - Lifetime
- 2002-04-11 OA OA1200300246A patent/OA12462A/fr unknown
- 2002-04-11 EA EA200301108A patent/EA008088B1/ru not_active IP Right Cessation
- 2002-04-11 PL PL363538A patent/PL204403B1/pl unknown
- 2002-04-11 US US10/474,811 patent/US7064109B2/en not_active Expired - Lifetime
- 2002-04-11 TN TNPCT/FR2002/001263A patent/TNSN03091A1/fr unknown
- 2002-04-11 CN CN02806447XA patent/CN1496270B/zh not_active Expired - Lifetime
-
2003
- 2003-09-26 MA MA27325A patent/MA27005A1/fr unknown
- 2003-10-02 ZA ZA200307718A patent/ZA200307718B/en unknown
-
2008
- 2008-08-28 CY CY20081100927T patent/CY1108302T1/el unknown
-
2009
- 2009-10-08 JP JP2009234250A patent/JP5170780B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200301108A1 (ru) | Фармацевтическая композиция на основе макролидов для местного применения в офтальмологии | |
| KR900700094A (ko) | 지방산과 모노글리세라이드의 항비루스 및 항세균 활성 | |
| KR950007850A (ko) | 항균물질 및 항궤양물질 포함 제제 | |
| KR930702014A (ko) | 시클로스포린 함유 외용 약제 | |
| EA200300634A1 (ru) | Фармацевтическая композиция, содержащая действующее вещество, диспергированное в матрице | |
| BR0111126A (pt) | Derivados de aminoácidos cìclicos úteis como agentes farmacêuticos | |
| BR0011347A (pt) | Preparações e formas de administração compreendendo um composto ativo de ácido instável | |
| BR0009286A (pt) | Formulação de propofol contendo tris | |
| EP0671162A3 (en) | Amphoteric compositions and polymer forms of alpha-hydroxy acids, and their therapeutic use. | |
| EA199800531A1 (ru) | Водные суспензии сложных эфиров жирной кислоты 9-гидроксирисперидона | |
| EA200100002A1 (ru) | Бензотиепины, обладающие активностью ингибиторов перемещения желчных кислот в подвздошной кишке и поглощения таурхолата | |
| BRPI0607569A2 (pt) | composição farmacêutica compreendendo estatina e ácidos graxos Èmega-3, na forma de dosagem unitária | |
| EA199700201A1 (ru) | Парентеральные фармацевтические композиции, содержащие алкиламмониевые соли 2-арилпропиновых кислот | |
| ATE318598T1 (de) | Antioxidierende stabilisierungssysteme für pharmazeutische formulierungen | |
| UY26303A1 (es) | Composiciones farmacéuticas para administración oral y tópica | |
| BR9802492A (pt) | Composição não aquosa para administração parenteral, e, processo para prevenir controlar ou tratar infecções ou infestações endo ou ectoparasitárias de helmintos, acarideos ou artrópodes em animais de sangue quente. | |
| KR930016391A (ko) | 긴 사슬의 지방족 알콜을 가진 아실카르니틴 에스테르와 항박테리아 활성을 지닌 그의 약제조성물 | |
| BR0312814A (pt) | Levamisol / avermectinas ou similares em solvente de pirrolidona | |
| AR004625A1 (es) | Composicion de un oseo activo que comprende una sustancia de un oseo activo y un carrier bilogico de dicha sustancia,composicion farmaceutica que comprende dicha composicion de un oseo-activo,y uso de dicha composicion para la preparacion de un medicamento | |
| US9549550B2 (en) | Method and composition for long acting bacterial suppression on skin | |
| KR960021018A (ko) | 약제학적 조성물 | |
| BR0215303A (pt) | Formulações farmacêuticas de base aquosa de pró-drogas solúveis em água de propofol | |
| BR0010454A (pt) | Composição farmacêutica contendo ciclosporina | |
| KR930702965A (ko) | 생체이용성이 개선된 프로부콜 함유 제약 조성물 | |
| AR007982A1 (es) | Procedimiento para la fabricacion catalitica de derivados de n-acilglicina y procedimiento para la fabricacion de aminoacidos opticamente puros. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM |
|
| MK4A | Patent expired |
Designated state(s): RU |